Effectiveness of Monovalent Rotavirus Vaccine Against Hospitalization With Acute Rotavirus Gastroenteritis in Kenyan Children
Author(s) -
Sammy Khagayi,
Richard Omore,
Grieven P. Otieno,
Billy Ogwel,
John B. Ochieng,
Jane Juma,
Evans Apondi,
Godfrey Bigogo,
Clayton Onyango,
Mwanajuma Ngama,
Regijeru,
Betty E. Owor,
Mike J. Mwanga,
O. Yaw Addo,
Collins Tabu,
Anyangu Amwayi,
Jason M. Mwenda,
Jacqueline E. Tate,
Umesh D. Parashar,
Robert F. Breiman,
D. James Nokes,
Jennifer R. Verani
Publication year - 2019
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciz664
Subject(s) - rotavirus , rotavirus vaccine , medicine , kenya , vaccination , pediatrics , odds ratio , confidence interval , diarrhea , underweight , malnutrition , logistic regression , immunization , immunology , body mass index , immune system , biology , overweight , ecology
Rotavirus remains a leading cause of pediatric diarrheal illness and death worldwide. Data on rotavirus vaccine effectiveness in sub-Saharan Africa are limited. Kenya introduced monovalent rotavirus vaccine (RV1) in July 2014. We assessed RV1 effectiveness against rotavirus-associated hospitalization in Kenyan children.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom